Literature DB >> 17582797

The regulation of uterine relaxation.

A López Bernal1.   

Abstract

The regulation of uterine relaxation is poorly understood but research in myometrial tissue and other types of smooth muscle has defined a number of receptors, ion channels and regulatory proteins that are likely to be involved. Some of these proteins are substrates for protein kinases, especially cyclic nucleotide dependent kinases. More research is necessary to identify the key molecules involved in the maintenance of uterine quiescence in pregnancy. The use of tocolytics in preterm labour remains controversial; there is a need to identify better pharmacological targets to provoke safe and selective uterine relaxation and improve neonatal outcome.

Mesh:

Substances:

Year:  2007        PMID: 17582797     DOI: 10.1016/j.semcdb.2007.05.002

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  14 in total

1.  Changes in rat myometrial plasma membrane protein kinase A are confined to parturition.

Authors:  Chun-Ying Ku; Dilyara A Murtazina; Yoon-Sun Kim; Robert E Garfield; Barbara M Sanborn
Journal:  Reprod Sci       Date:  2010-05-10       Impact factor: 3.060

Review 2.  A close look at the contraction and relaxation of the myometrium; the role of calcium.

Authors:  Bilge Pehlivanoğlu; Sibel Bayrak; Murat Doğan
Journal:  J Turk Ger Gynecol Assoc       Date:  2013-12-01

3.  Multiple signals regulate phospholipase CBeta3 in human myometrial cells.

Authors:  Miao Zhong; Dilyara A Murtazina; Jennifer Phillips; Chun-Ying Ku; Barbara M Sanborn
Journal:  Biol Reprod       Date:  2008-03-05       Impact factor: 4.285

4.  ADP-ribosylation factor 6 expression and activation are reduced in myometrium in complicated pregnancies.

Authors:  Venkateswarlu Kanamarlapudi; Sian E Owens; Jon Lartey; Andrés López Bernal
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

Review 5.  Prevention of preterm labour: 2011 update on tocolysis.

Authors:  C Hubinont; F Debieve
Journal:  J Pregnancy       Date:  2011-11-15

Review 6.  Tocolysis: Present and future treatment options.

Authors:  Joshua D Younger; Elena Reitman; George Gallos
Journal:  Semin Perinatol       Date:  2017-12       Impact factor: 3.311

Review 7.  Functional insights into modulation of BKCa channel activity to alter myometrial contractility.

Authors:  Ramón A Lorca; Monali Prabagaran; Sarah K England
Journal:  Front Physiol       Date:  2014-07-31       Impact factor: 4.566

8.  Expression of HIV-1 Vpu leads to loss of the viral restriction factor CD317/Tetherin from lipid rafts and its enhanced lysosomal degradation.

Authors:  Ruth Rollason; Katie Dunstan; Peter G Billcliff; Paul Bishop; Paul Gleeson; Helen Wise; Paul Digard; George Banting
Journal:  PLoS One       Date:  2013-09-24       Impact factor: 3.240

9.  The BRAzil MAGnesium (BRAMAG) trial: a randomized clinical trial of oral magnesium supplementation in pregnancy for the prevention of preterm birth and perinatal and maternal morbidity.

Authors:  Joao Guilherme B Alves; Carla Adriane Fonseca Leal de Araújo; Isabelle E A Pontes; Angélica C Guimarães; Joel G Ray
Journal:  BMC Pregnancy Childbirth       Date:  2014-07-08       Impact factor: 3.007

10.  Evaluating aminophylline and progesterone combination treatment to modulate contractility and labor-related proteins in pregnant human myometrial tissues.

Authors:  Pei F Lai; Roger C Young; Rachel M Tribe; Mark R Johnson
Journal:  Pharmacol Res Perspect       Date:  2021-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.